February 2, 2009 / 3:48 PM / 11 years ago

UPDATE 1-Haemonetics Q3 tops Street, raises FY09 view

* Q3 results top market estimates

* Sees FY09 EPS $2.40-$2.44, prior view $2.38-$2.44

* Sees FY09 rev growth 15-16 pct, prior view 12-14 pct

* Shares up 7 pct

Feb 2 (Reuters) - Automated blood-processing systems maker Haemonetics Corp (HAE.N) posted better-than-expected quarterly earnings and raised its outlook for 2009, citing strong product sales, sending its shares up almost 7 percent.

For the third quarter, the company reported a net profit of $16.2 million, or 62 cents a share, compared with $14.4 million, or 54 cents a share, a year earlier. Excluding restructuring charges, the company earned 63 cents a share.

Sales rose 16 percent to $155.4 million for the quarter ended Dec. 27, 2008, boosted by revenue from plasma disposables and blood bank disposables.

Revenue for the plasma disposables, its largest business, rose 30 percent to $54 million, while revenue for its blood bank disposables rose 10 percent to $36 million.

Haemonetics collects and processes components of blood that are used in surgeries and transfusions.

Shares of the Braintree, Massachusetts-based company were up $3 at $62.15 in Monday morning trade on the New York Stock Exchange. They touched a high of $63.18 earlier in the session.

For the alerts, please double click [ID:nWNAB6816]

For the press release double click [ID:nPnNE64097] (Reporting by Anuradha Ramanathan in Bangalore; Editing by Himani Sarkar)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below